Core Viewpoint - Faraday Future (FFAI.US) stock price declined over 8% to $1.625 following the announcement of a $41 million investment in Qualigen Therapeutics (QLGN.US) to support its entry into the crypto and Web3 sectors [1] Group 1: Company Actions - Faraday Future announced a $41 million investment in Qualigen Therapeutics to facilitate its expansion into the crypto and Web3 markets [1] - This investment will provide Faraday Future with significant equity in Qualigen and plans to appoint a management team to lead new business activities [1] Group 2: Market Reactions - Following the investment announcement, Qualigen Therapeutics' stock surged over 95%, reaching $5.55 [1]

Core Viewpoint - Faraday Future (FFAI.US) stock price declined over 8% to $1.625 following the announcement of a $41 million investment in Qualigen Therapeutics (QLGN.US) to support its entry into the crypto and Web3 sectors [1] Group 1 - Faraday Future's investment in Qualigen Therapeutics amounts to $41 million [1] - Following the investment announcement, Qualigen Therapeutics' stock surged over 95% to $5.55 [1] - The investment will provide Faraday Future with significant equity in Qualigen and plans to assign a management team to lead new business activities [1]

Market Overview - U.S. stocks traded mostly lower, with the Dow Jones index falling more than 100 points, down 0.25% to 46,201.74, while the NASDAQ rose 0.05% to 22,642.88 and the S&P 500 dropped 0.07% to 6,659.98 [1] - European shares were mostly lower, with the eurozone's STOXX 600 falling 0.3%, Spain's IBEX 35 Index down 1.1%, London's FTSE 100 up 0.1%, Germany's DAX 40 down 0.7%, and France's CAC 40 down 0.5% [5] - Asian markets closed mixed, with Japan's Nikkei gaining 0.99%, Hong Kong's Hang Seng dipping 0.76%, China's Shanghai Composite rising 0.22%, and India's BSE Sensex falling 0.56% [6] Sector Performance - Consumer discretionary shares increased by 0.2% on Monday, while energy stocks fell by 0.6% [1] Commodity Prices - Oil traded down 0.6% to $62.28, while gold rose 1.3% to $3,755.20. Silver increased by 1.9% to $43.780, and copper fell 0.2% to $4.6170 [4] Company News - AgriFORCE Growing Systems Ltd. shares surged 220% to $7.70 after announcing a name change to AVAX One and plans to raise approximately $550 million [9] - Qualigen Therapeutics, Inc. shares rose 152% to $7.16 following a $41 million investment from Faraday Future [9] - MBX Biosciences, Inc. shares increased by 140% to $24.00 after reporting that its Canvuparatide achieved primary endpoint in a Phase 2 trial [9] - Chijet Motor Company, Inc. shares dropped 32% to $0.1970 after naming Jason Miller as COO [9] - AtlasClear Holdings, Inc. shares fell 30% to $0.6401, and AlphaVest Acquisition Corp shares decreased by 27% to $16.16 [9]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - AgriFORCE Growing Systems Ltd. (AGRI) has increased by 263% to $8.73 [3] - Qualigen Therapeutics, Inc. (QLGN) has risen by 212% to $8.87 [3] - Flora Growth Corp. (FLGC) is up 103% at $55.36 [3] - Boxlight Corporation (BOXL) has gained 102% to $3.16 [3] - Platinum Analytics Cayman Limited (PLTS) is up 96% at $14.00 [3] - Metsera, Inc. (MTSR) has increased by 59% to $52.99 [3] - Anywhere Real Estate Inc. (HOUS) is up 51% at $10.72 [3] - Fold Holdings, Inc. (FLD) has risen by 30% to $5.93 [3] - ARB IOT Group Limited (ARBB) is up 28% at $8.02 [3] - MBX Biosciences, Inc. (MBX) has increased by 26% to $12.64 [3] Premarket Losers - AlphaVest Acquisition Corp (ATMV) has decreased by 27% to $15.99 [4] - Helius Medical Technologies, Inc. (HSDT) is down 17% at $20.00 [4] - CEA Industries Inc. (BNC) has fallen by 15% to $8.20 [4] - Simpple Ltd. (SPPL) is down 13% at $5.00 [4] - FatPipe, Inc. (FATN) has decreased by 11% to $7.87 [4] - Tharimmune, Inc. (THAR) is down 11% at $3.20 [4] - Yueda Digital Holding (YDKG) has fallen by 11% to $2.98 [4] - American Battery Technology Company (ABAT) is down 10% at $2.94 [4] - AGM Group Holdings Inc. (AGMH) has decreased by 9% to $9.36 [4] - Antelope Enterprise Holdings Limited (AEHL) is down 5% at $3.38 [4]

Core Viewpoint - Qualigen Therapeutics has entered into a PIPE agreement with Faraday Future, involving a financing of approximately $41 million, aimed at transitioning the company towards cryptocurrency and Web3-related businesses [4][6]. Financing Details - The financing round is led by Faraday Future and its CEO Jia Yueting, with a total investment of about $41 million, including $30 million from Faraday Future at a price of $2.246 per share, giving it a 55% ownership stake in Qualigen [4][6]. - Jia Yueting plans to invest an additional $4 million personally, acquiring about 7% of Qualigen's common stock [4][6]. Strategic Shift - Following the investment, Qualigen is expected to rebrand as CXC10 and focus on cryptocurrency and Web3, moving away from its current biopharmaceutical operations, which are struggling [6][10]. - The company aims to create a new business model centered around a crypto ecosystem, decentralized AI trading, and value stabilization [6][10]. Company Background - Qualigen has faced significant challenges, including a risk of delisting from NASDAQ due to its stock price falling below $1 for 30 consecutive days [8][9]. - Recent leadership changes occurred as the previous CEO and CFO resigned due to strategic disagreements, leading to the appointment of new executives with experience in turning around small-cap companies [9][10]. Current Operations - Qualigen's core product pipeline focuses on rare cancer treatments, with ongoing projects like QN-302 in Phase 1 trials and Pan-RAS in lead optimization [10]. - Despite the strategic investment, the company has not shown substantial operational improvements, and its future remains uncertain in the highly competitive biopharmaceutical industry [10].

Core Viewpoint - Qualigen Therapeutics has entered into a PIPE agreement with Faraday Future, involving a $41 million investment focused on cryptocurrency and Web3 business planning [2][4] Group 1: Investment Details - The financing amount is approximately $41 million, led by Faraday Future and its CEO Jia Yueting, with participation from other investors including the SIGN Foundation [2] - Faraday Future will invest about $30 million in Qualigen at a price of $2.246 per share, acquiring approximately 55% of the common stock [2] - Jia Yueting plans to invest around $4 million personally, corresponding to about 7% of Qualigen's common stock [2] Group 2: Strategic Shift - Following the investment, Qualigen is expected to rebrand as CXC10 and shift its focus towards cryptocurrency and Web3, moving away from its current biopharmaceutical operations [4] - The new business model will emphasize a "three-horsepower" strategy involving Crypto, a decentralized AI trading exchange, and a value stabilizer [4] - After the investment, Faraday Future and Jia Yueting will collectively hold 62% of Qualigen's shares, with plans for management involvement [4] Group 3: Company Background and Challenges - Qualigen has faced significant challenges, including a risk of delisting from NASDAQ due to stock price issues, with a recent notification received for failing to meet minimum price requirements [6][7] - The company has experienced leadership changes, with recent resignations of key executives due to strategic disagreements [6][7] - Qualigen's core product pipeline is focused on rare cancer treatments, but progress has been slow, with key projects still in early development stages [7][8]

Core Viewpoint - Faraday Future Intelligent Electric Inc. is strategically investing approximately $30 million in Qualigen Therapeutics, Inc. to initiate a crypto and web3-related business, aiming to enhance its dual-flywheel and dual-bridge eco strategy to maximize shareholder value [1][2][8] Investment Details - The total investment in Qualigen Therapeutics will be around $41 million, with Faraday Future contributing about $30 million for approximately 55% of QLGN's common stock on a pro forma basis [2][3] - YT Jia, Founder & Global Co-CEO, will invest $4 million and receive about 7% of QLGN's common stock, with a two-year lockup on his shares [3][4] Management and Governance - Faraday Future plans to assign management teams to oversee relevant business activities, with YT Jia serving as chief advisor to QLGN and Jerry Wang expected to be appointed as Co-CEO [4] - Following the investment, Faraday Future will have the right to nominate two of five directors on QLGN's board, which could increase to four of seven if stockholder approval is obtained [4] Rebranding and Product Focus - Qualigen Therapeutics is expected to rebrand as CXC10, focusing on three growth engines in the crypto ecosystem, including the C10 Treasury, BesTrade DeAI Agent, and ecosystem tokens [5][6][7] - The C10 Treasury has shown an unrealized gain of around 7%, outperforming the C10 index, with a 20% actively managed allocation yielding positive results [9] Product Innovations - The FX Super One MPV was showcased at the annual 919 event, featuring an ultra-wide dual-screen panoramic display and advanced EAI OS for enhanced user interaction [10][12][13] - The EAI Space in the FX Super One is designed to provide a personalized and immersive experience, integrating hardware, software, and applications for seamless user engagement [15][16][17] Future Outlook - Faraday Future aims to bridge Web2 and Web3, as well as AI and crypto, positioning itself as a leading U.S. public company in the evolving digital landscape [6][9]

Investment Announcement - Faraday Future announced a strategic investment of approximately $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) during its annual 919 event, focusing on its crypto business and three growth engines [1][4][21] - The investment will be led by Faraday Future, with founder YT Jia contributing approximately $4 million through an FFGP loan, which includes a two-year lockup on his shares [6][9][10] Growth Strategy - Qualigen Therapeutics is expected to rebrand as CXC10, targeting to become a leading U.S. public company that bridges Web2 and Web3, as well as AI and crypto [11][21] - The three growth engines include: 1. C10, the value anchor, which encompasses the C10 Treasury, C10 Index, and a potential C10 ETF 2. BesTrade DeAI Agent, an AI-driven product to assist users in trading 3. Ecosystem tokens, which include a stablecoin and a dual-bridge product [12][13][21] Financial Performance - As of September 18, the C10 Treasury had completed about $10 million in crypto asset allocations, delivering an unrealized gain of around 7%, outperforming the C10 index [14][21] Product Development - Faraday Future unveiled its ultra-wide dual-screen panoramic display for the FX Super One MPV at the 919 event, designed to enhance both driving and entertainment experiences [3][21] - The FX Super One is on track for its first vehicle to roll off the line by year-end in the U.S., with the Middle East launch expected by the end of October [16][21]

Group 1 - Faraday Future announced a strategic investment in Nasdaq-listed QLGN, which will be renamed CXC10, during its 919 Futurist Day and Shareholder Community Day held in Los Angeles [1][3] - The investment is led by Faraday Future, with participation from its founder and Co-CEO Jia Yueting, along with other investors including Binance Labs, Sequoia Capital, IDG, and Circle-supported SIGN Foundation [3] - The strategic investment is expected to exceed $41 million, subject to shareholder approval and other closing conditions, with Jia Yueting committing $4 million as a cornerstone investor and voluntarily locking up shares for two years [3] Group 2 - Jia Yueting plans to establish a second creditor trust, allocating 50% of the equity incentives received from his Co-CEO position and half of the profits from the $4 million investment after repaying the loan and related costs to the trust for debt repayment and vehicle manufacturing [3]

Core Viewpoint - Faraday Future (FF) is set to become one of the fastest companies to split and go public on NASDAQ through its strategic investment in QLGN, amounting to $41 million, led by founder Jia Yueting [1][4]. Group 1: Strategic Investment and Business Focus - FF announced a strategic investment of $41 million in NASDAQ-listed QLGN, with Jia Yueting personally investing $4 million, aiming to enhance its focus on Crypto and Web3 ecosystem development [1][3]. - The investment signifies the acceleration of FF's "dual flywheel and dual bridge strategy," which aims to maximize value for both shareholders and blockchain community members [3][4]. - Following the investment, FF will hold approximately 62% of QLGN, with Jia Yueting serving as Chief Advisor and FF's global president Jerry Wang as Co-CEO [5][4]. Group 2: Business Model and Product Development - The split of the Crypto flywheel business is expected to create a new record for the fastest IPO in NASDAQ history, with the goal of establishing the first stock combining Web2+Web3 and EAI+Crypto [4][5]. - QLGN will be renamed CXC10, representing the three driving forces of the business: the Crypto ecosystem token system, the parent exchange DeAI Agent, and the value stabilizer [5][10]. - The company plans to launch six major products under the Crypto "three driving forces," including C10 Treasury, C10 Index, C10 ETF, and the BestTrade DeAI Agent [10]. Group 3: Debt Management and Commitment - Jia Yueting announced the establishment of a second creditor trust, committing half of the equity incentives received from his Co-CEO position and half of the profits from his $4 million investment to repay debts under Chinese law [11]. - He emphasized his commitment to fulfilling obligations related to debts, despite having resolved his debts in the U.S. [11].